Holdings
AlphaCentric Advisors LLC
As of Sep 30, 2026, AlphaCentric Advisors LLC reported 234 positions worth US$106M. Largest: iShares 1-3 Year Treasury Bond ETF, Gilead Sciences, Inc. and iShares Russell 1000 Value ETF. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| iShares 1-3 Year Treasury Bond ETF | 66,011 | US$5.36M | new | Sep 30, 2026 |
| Gilead Sciences, Inc. | 21,278 | US$3.17M | +852 | Sep 30, 2026 |
| iShares Russell 1000 Value ETF | 12,020 | US$2.98M | new | Sep 30, 2026 |
| Invesco S&P 500 Pure Value ETF | 25,447 | US$2.92M | new | Sep 30, 2026 |
| Vertex Pharmaceuticals Incorporated | 5,115 | US$2.67M | +113 | Sep 30, 2026 |
| Invitation Homes Inc. | 73,000 | US$1.92M | no change | Sep 30, 2026 |
| Roivant Sciences Ltd. | 50,535 | US$1.85M | +2,180 | Sep 30, 2026 |
| Incyte Corporation | 15,140 | US$1.84M | +689 | Sep 30, 2026 |
| argenx SE | 1,841 | US$1.77M | +35 | Sep 30, 2026 |
| Neurocrine Biosciences, Inc. | 10,230 | US$1.45M | +503 | Sep 30, 2026 |